The rise of antibiotic resistance demands urgent research into its molecular mechanisms to inform the development of ...

Rapid technological and social change is a powerfully disruptive force – a wave of creative destruction – leaving in its wake ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

T cells are positioned at the frontline of the body's immune system to fight infection, cancer, and autoimmune disease. While ...

A new computational tool allows researchers to understand how the diverse cell types of the human body are made during ...

Robles BioCeutics, a regenerative dermatology biotechnology company focused on developing next-generation skin care solutions through stem cell and senolytic technologies, is pleased to announce the ...

A: “We implemented a new cellphone policy this year that significantly limits cell phones in schools,” said Eva Craner, ...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

The pioneering research of UC Santa Cruz’s Upasna Sharma to determine how a father’s life experiences and environment can ...

Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...

AbCellera announced financial results for the full year 2024. FY 2024 total revenue was $28.8 million, compared to $38.0 million in 2023. Net loss was $162.9 million, compared to $146.4 million in ...